EDmicBio Inc. logo

EDmicBio Inc.

Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human

3 employees · est. 2019 · Seoul, Korea South

VS
Svelte Medical Systems logo

Svelte Medical Systems

Advancing coronary care with innovative, highly deliverable stent solutions designed for safety and efficiency.

est. 2007

Svelte Medical Systems is the older company (2019 vs 2007).

Side-by-Side Comparison

EDmicBio Inc. Svelte Medical Systems
Founded
2019 2007 older
Headquarters
Seoul, Korea South Not tracked yet
Employees
3 Not tracked yet
Industry
Information Technology Health Care, Medical Devices
Funding Stage
Seed Series Unknown
Total Funding
Not tracked yet $128.41M
Funding Rounds
1 11
Services
Development of 3D organ-on-a-chip platforms, Research on drug discovery, Solutions for disease treatment Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Healthcare Institutions, Research Laboratories Not tracked yet
Taxonomy
3D Bioprinting, Organ-on-a-chip, Tissue Engineering, Stent Development, Biodegradable Medical Devices, Bioink Technology, Drug Testing Platforms, 3D Printing Systems, Microfluidics, In-vitro Drug Testing, Patient-specific Drug Development, Organ Fabrication, Biochemical Environment Mimicry, New Drug Development, Animal Testing Replacement Coronary Stent Market, Stent Deliverability, Balloon-Expandable Stent, Drug-Eluting Stent, Non-Thrombogenic Technology, Non-Inflammatory Technology, Medical Device Innovation, Clinical Safety Enhancement, Cost Reduction In Medical Devices, Privately Held Medical Company, Cardiovascular Healthcare, Biomedical Engineering, Interventional Cardiology
Website
edmicbio.com sveltemedical.com
EDmicBio Inc. logo

About EDmicBio Inc.

EDmicBio Inc., established in 2019 and headquartered in Korea South, is pioneering the frontier of 3D bioprinting technology. With the innovative mission to “Investigate your drug with 3D biomimicry, 3D organ-on-a-chip. We can build a better future for humans,” this startup expertly combines fields...

Svelte Medical Systems logo

About Svelte Medical Systems

Svelte Medical Systems, founded in 2007 by Robert Fischell, David Fischell, and Tim Fischell, is positioned within the burgeoning $5 billion coronary stent market. Operating in the Health Care and Medical Devices sectors, the company aims to revolutionize coronary care with its innovative stent solu...

We will tell you when either one moves

BounceWatch watches EDmicBio Inc. and Svelte Medical Systems for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EDmicBio Inc. and Svelte Medical Systems — by email.

Frequently Asked Questions

EDmicBio Inc. — Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human. Svelte Medical Systems — Advancing coronary care with innovative, highly deliverable stent solutions designed for safety and efficiency.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EDmicBio Inc. has raised undisclosed funding while Svelte Medical Systems has raised $128.41M.
EDmicBio Inc. and Svelte Medical Systems operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EDmicBio Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EDmicBio Inc. on 12 Apr 2026, and Svelte Medical Systems on 22 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes